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Background: Benzodiazepines (BZDs), the most commonly prescribed psychotropic
drugs with anxiolytic action, may cause hyposalivation. It has been previously shown
that BZDs can cause hypertrophy and decrease the acini cell number. In this study, we
investigated the effects of BZDs and pilocarpine on rat parotid glands, specifically on
acinar, ductal, and myoepithelial cells.
Methods: Ninety male Wistar rats were divided into nine groups. Control groups
received a saline solution for 30 days (C30) and 60 days (C60), and pilocarpine (PILO)
for 60 days. Experimental groups received lorazepam (L30) and midazolam (M30) for 30
days. Another group (LS60 or MS60) received lorazepam or midazolam for 30 days,
respectively, and saline for additional 30 days. Finally, other groups (LP60 or MP60)
received either lorazepam or midazolam for 30 days, respectively, and pilocarpine for
additional 30 days. The expression of calponin in myoepithelial cells and the proliferating
cell nuclear antigen (PCNA) in acinar and ductal cells were evaluated.
Results: Animals treated with lorazepam showed an increase in the number of positive
staining cells for calponin as compared to control animals (p < 0.05). Midazolam
administered with pilocarpine (MP60) induced an increase in the proliferation of acinar
and ductal cells and a decrease in the positive staining cells for calponin as compared
to midazolam administered with saline (MS60).
Conclusion: We found that myoepithelial cells might be more sensitive to the effects
of BZD than acinar and ductal cells in rat parotid glands.
Keywords: benzodiazepines, immunohistochemistry, salivary glands, dry mouth, GABAA receptor
Abbreviations: BZDs, Benzodiazepines; C 30, Saline for 30 days; C60, Saline for 60 days, PILO pilocarpine; L30, Lorazepam
for 30 days, M30, Midazolam 30 days; LS60, Lorazepam 30 days + Saline 30 days; MS60, Midazolam 30 days + Saline
30 days; PCNA, proliferating cell nuclear antigen; SSFR, stimulated salivary flow rate ; CV, cellular volume; GABA,
Gamma-aminobutyric acid; TMAs, tissue microarrays.
Mattioli et al. Benzodiazepines and Dry Mounth
INTRODUCTION
Benzodiazepines (BZDs) are a group of drugs used as anxiolytics,
hypnotics, sedatives, muscle relaxants, and anticonvulsants.
These drugs have largely been substituted by barbiturates.
However, unlike barbiturates, BZDs do not produce a depressive
action of the respiratory system and are thus safer and have a
greater specificity for treating anxiety symptoms (Howard et al.,
2014). BZDs comprise nearly 50% of all prescribed psychotropic
drugs (Lader et al., 2009).
BZDs bind at the interface of two subunits (alpha and gamma
subunits) of gamma-Aminobutyric acid (GABA) receptor type
A. It is well-known that GABA is an inhibitory neurotransmitter
of the central nervous system (CNS). BZDs facilitate the action
of GABA at the GABAA receptors. GABA is a neurotransmitter
that has an action in increasing chloride influx, which can lead to
hyperpolarization of neurons, thereby inhibiting the generation
of an action potential (Howard et al., 2014).
BZDs produce a wide range of adverse effects, including
hyposalivation and xerostomia (De Almeida Pdel et al., 2008).
Since the last decade, the effect of BZDs in the regulation of
salivary secretion, in rat parotid acinar cells, has been widely
studied (Okubo and Kawaguchi, 1998). One study has shown that
diazepam can decrease salivary secretion by the parotid gland,
which involves an inhibitory effect on IP3 and calcium as well as
blockade of muscarinic receptor (Kujirai et al., 2002).
It is noteworthy that myoepithelial cells of the salivary glands
are located between the basal layer and plasmatic membrane of
the secretory acinar cells and interspersed ducts (Klein, 2002).
These are characterized by high expression of actin and myosin
myofilaments in their cytoplasm, which make their contractility
one of their main functions. Myoepithelial cells are highly
specialized and possess a double phenotype (smooth epithelial
and muscular) and contribute to the drainage from secretory and
ductal units. Cells are characterized by the presence of calponin
antigen, a protein involved in the system that regulates the
contraction of the smooth muscle (Rao et al., 2014).
It is noteworthy that the proliferating cell nuclear anti-
antigen (PCNA) is a monoclonal antibody that allows studying
the cell kinetics (Wang, 2014) and is therefore a marker of
cell proliferation capable of identifying proliferating acinar and
ductal cells (Mattioli et al., 2011). Our laboratory has investigated
the effect of chronic treatment of BDZ and antidepressant on
the parotid glands of Wistar rats and found hyposalivation and
hypertrophy of the serous cells. These findings suggest a possible
inhibition of the activity of myoepithelial cells stemming from
nervous stimulation, a reduction in the number of these cells with
chronic use of psychotropic drugs, or a change in the number
of acinar and ductal cells (Zaclikevis et al., 2009; Mattioli et al.,
2011).
In previous studies (da Silva et al., 2009; Zaclikevis et al.,
2009) conducted by our research group, came the question: Since
the BZD reduced salivary flow and caused acinar hypertrophy,
it was hypothesized that it could be occurring a decrease
in mioepitelias cells and/or a reduction of the acinar cells
proliferation, respectively evaluated by calponin and PCNA,
which is the aim of the present study. In the same studies it also
verified that pilocarpine (patent deposited of this research group)
reestabished salivary flow which had been reduced with the
administration of BZDs. It has been postulated that pilocarpine
could then be acting on the myoepithelial cells and/ or interfering
with the acinar proliferation, which is also the aim of the present
study.
Different drugs selected form because there are the important
qualitative and quantitative differences in the pharmacokinetics
when comparing midazolam and lorazepam that need to
be discussed. Lorazepam is a drug that does not produce
active metabolites, and it has a short half-life (12–18 h). By
contrast, midazolam contains an active metabolite (hydroxylated
derivative) with a half-life of 2 h. The half-life of midazolam is
also extremely short (<6 h; De Almeida et al., 2012).
Therefore, the present study aims to investigate the presence
of the myoepithelial, and proliferation acinar and ductal cells
in rat parotid glands treated with midazolam and lorazepam
using immunocytochemistry technique with antibodies against
calponin and PCNA. We also investigate the effect of topical
administration of pilocarpine in the parotid glands treated with
BDZ.
MATERIALS AND METHOD
Animals
All experimental procedures followed the guidelines of the
Didactic-Scientific Vivisection of Animals as well as the Ethical
Principles of Animal Experimentation in accordance with Law
6.638 of May 08, 1979 (Goldim, 1985). This study was approved
by the Research Ethics Committee at Universidade Tuiuti
do Parana (CEP-UTP/55). See more details in Supplementary
Materials about Ethical Committee.
This study used 90 male Wistar rats, at a body weight of
250 g, which were provided by the Central Vivarium of the
Pontifical Catholic University of Parana (under the supervision
of the Animal Committee). Rats were kept under controlled
temperature (25◦ ± 2◦C) and relative humidity (50 ± 15%)
conditions, normal photoperiod (12 h light/dark cycle). Rats
had access to water and ad libitum food (PurinaTM). Animals
were housed throughout the experiments in polypropylene cages
containing sterile paddy husk (locally supplied) as bedding, with
four animals per cage.
Treatments
The animals were divided into nine groups with ten animals
per group. Groups of animals received different treatments (C30,
C60, PILO, L30, M30, LS60, MS60, LP60, andMP60) as described
in Table 1.
Immunocytochemistry and
Immunochemical Analysis
Parotid glands from male Wistar rats were submerged
in paraffin blocks We used tissue microarrays (TMAs)
containing ten cylinders of paraffinized salivary glands (3
um in diameters), which were organized in lines and columns
(Rocha et al., 2006; Schuler et al., 2008). Each TMA exhibited
ten specimens of salivary glands from rats of each group.
For immunohistochemistry, anti-calponin, and anti-PCNA
(Dako CytomationH; Dako North America, Carpinteria, CA,
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TABLE 1 | Division of the control and experimental groups according to
the medication, treatment period, daily dose, and route of administration.
Groups n Drugs Treatment Dose Route of
period Administration
1- C30 10 Saline 1–30 days 0.1 mL Intraperitoneal
2- C60 10 Saline 1–60 days 0.1 mL Intraperitoneal
3- PILO 10 Pilocarpinea 1–60 days 0.05 mL Topical
4- L30 10 Lorazepamb 1–30 days 0.5 mg/kg Intramuscular
5- M30 10 Midazolamc 1–30 days 0.1 mg/kg Intramuscular
6- LS60 10 Lorazepam 1–30 days 0.5 mg/kg Intramuscular
Saline 31–60 days 0.1 mL Intraperitoneal
7- MS60 10 Midazolam 1–30 days 0.1 mg/kg Intramuscular
Saline 31–60 days 0.1 mL Intraperitoneal
8- LP60 10 Lorazepam 1–30 days 0.5 mg/kg Intramuscular
Lorazepam +
Pilocarpine
31–60 days 0.05 mL Intramuscular
and topical
9- MP60 10 Midazolam 1–30 days 0.1 mg/kg Intramuscular
Midazolam +
Pilocarpine
31–60 days 0.05 mL Intramuscular
and topical
N, sample size.
aOrabase gel prepared with 1% pilocarpine hydrochloride (Gerbras Química e
Farmacêutica Ltda., São Paulo, Brasil).
bLorazepam (Cosmética Farmácia de Manipulação Ltda, Curitiba, Paraná, Brazil).
cMidazolam (Cosmética Farmácia de Manipulação Ltda, Curitiba, Paraná, Brazil).
USA), antibodies were used. The secondary antibody was
EnVisionH+Dual Link/Peroxidase (Dako CytomationH),
and the peroxidase reactions were revealed with DAB
substrate-chromogen system (Dako CytomationH). Slides
were counterstained with Harris hematoxylin. We used anti-
calponin monoclonal antibody at 1:800 for myoepithelial cell
staining and anti-PCNA antibody at 1:400 for staining of
proliferating acinar and ductal cells. PCNA is a monoclonal
antibody that allows the study of cell kinetics.
Sections were visualized by only one examiner using an
OlympusH BX50 optical microscope (Olympus Corporation,
Ishikawa, Japan) with a 40X objective. Expression of calponin
in the myoepithelial cells and PCNA in the acinar and ductal
cells were analyzed using the entire TMA area. The presence
or absence of staining of PCNA and calponin antibodies was
evaluated. Cells that exhibited expression for PCNA in the
glandular epithelium were considered positive (represented
by a brownish staining), regardless of the staining intensity.
To analyse the positivity to calponin, the identification of
the myoepithelial cells was based on their morphology and
location followed described associated with a cytoplasmatic
brownish staining. Also the observer was calibrate, due to that
only marking the cells in which the nucleus was considered.
Myoepithelial cells are normal constituent of the salivary
acini and smaller ducts, and are found between the epithelial
cells and the basement membrane. Microscopic examination
shows that myoepithelial cells are thin and spindle-shaped and
situated between the basement membrane and epithelial cells
(Balachander et al., 2015).
There were 24 histological fields in each cylinder of
paraffinized tissue. Before counting the number of stained cells,
we verified the number of fields (out of 24). Therefore, the
integrity and quality of the tissue as well as the presence of
technical artifacts were taken into consideration. After evaluating
the 24 histological fields of all cylinders, the numerical indices
for the positive staining of cells for calponin and for PCNA were
obtained.
To determine the average value of stained cells for calponin
and PCNA from each cylinder, the average value of stained cells
in a cylinder was represented by the sum of the number of
stained cells for the antibody in each evaluated field divided by
the number of evaluated fields. After obtaining the average value
for each cylinder, the values were added together and divided by
10 (equivalent to the total number of TMAs), which resulted in
the average value of stained cells for each group. See more details
in Supplementary Materials about histological analysis.
In addition to calponin and PCNA variables, this study also
used the average values for the stimulated salivary flow rate
(SSFR) and cellular volume (CV) as determined in a study by
Rinaldi et al. (2015). Because the present study investigated
the same sample as was performed previously (Rinaldi et al.,
2015), the SSFR and CV findings were compared to the
immunohistochemical staining results for calponin and PCNA.
Statistical Analysis
Data were analyzed using SPSS software. Normality analysis was
performed using the Kolmogorov-Smirnov test. The Levene test
was used to analyze the variance of homogeneity. For the groups
with a normal distribution, analysis of variance (ANOVA) at one
criterion was performed. When ANOVA at one criterion showed
differences among the groups and treatment, the Tukey HSD
multiple comparison test was used for variables that presented
variance of homogeneity among the groups. For the variables that
did not present variance homogeneity, the Games-Howell test
was used. The level of significance for all statistical tests was set at
5% (p < 0.05). The analyzed variables were calponin and PNCA,
which were compared to the CV and SSFR variables (Rinaldi
et al., 2015). See more details in Supplementary Materials about
statistical analysis.
RESULTS
L30 and M30 showed lower values to SSFR (Graphic 1 and
Table 2 respectively) and higher to CV (Graphic 2 and Table 2)
when compared with C30. L30 showed higher value to number
of C when compared to C30 (Graphic 3, Figures 1, 2). None
differences to PCNA was observed comparison L30 and M30 to
C30 (Graphic 4 and Table 2).
LP60 and MP60 showed similar values to SSFR (Graphic 1
and Table 3) when compared to C60. None differences to SSRF
was observed comparison LS60 or MS60 to C60 (Graphic 1 and
Table 3). LS60 or LP60 revealed higher values to C as compared
to C60 (Graphic 3). MP60 showed higher PCNA (Figures 3, 4)
and lower C as compared to MS60 (Table 3).
DISCUSSION
Chronic use of lorazepam and midazolam for 30 days induced a
reduction in the SSFR and an increase in the CV in rat parotid
glands. Lorazepam, when administered for 30 days (L30 group),
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increased the number of myoepithelial cells when compared to
the saline group (C30). When pilocarpine was administered with
lorazepam or midazolam for 60 days, pilocarpine attenuated the
deficit in SSFR. Administration of lorazepam with saline solution
(LS60) or pilocarpine (LP60) caused an increase in the number of
myoepithelial cells as compared to the groups that received only
saline solution (C60). When pilocarpine was administered with
midazolam (MP60), there were an increase in the proliferation
of acinar and ductal cells and a reduction in the number of
myoepithelial cells as compared to the groups that received
midazolam and saline (MS60).
Chronic treatment with lorazepam and midazolam for 30
days induced reduction of SSFR in rats. In groups treated for
30 days, the reduction of SSFR was more pronounced than in
Graphic 1 | Box-plots to Stimulated Salivary Flow Rate (SSFR -
mL/min) according to the groups treated for: 30 and 60 days with
saline (C30 and C60 respectively); pilocarpine (P60), lorazepam (L30),
lorazepam and saline (LS60), and lorazepam and pilocarpine (LP60).
Comparisons with p < 0.05: L30 × C30; P60 × LS60; LS60 × LP60. CI
95% = 95% confidence interval. Data obtained from findings reported by
Rinaldi et al. (2015).
TABLE 2 | Average values, standard deviation, and p-value studied
according to the groups treated for 30 days with saline (C30), and
midazolam (M30).
Groups C30 M30
X DP X DP
SSFR (mL/min)δ 0.051 ± 0.025a 0.019 ± 0.009a
CV (µm3)δ 6965.68 ±3792.96a 20036.56 ± 7955.70a
C 13.9 ± 2.6 15.3 ± 7.1
PCNA 55.8 ± 14.4 39.6 ± 30.0
δValues obtained from findings reported by Rinaldi et al. (2015); SSFR (mL/min),
Stimulated salivary flow rate in millimeters per minute; CV, Cell volume in square
micrometers; PCNA, Proliferating Cell Nuclear Antigen; C, Antibody against calponin
antigen; X, average; SD, standard deviation;p, p-value of ANOVA;Similar letter represents
statistically significant difference between the groups.
groups treated for 60 days. It is important to note that in the
groups treated for 60 days (MS60 and LS60), administration
of medication were suspended at the final 30 days and after
this period the animals received only saline. It is possible
that this may allow for a reorganization of the physiology of
salivary secretion in the parotid glands. To investigate these
findings further, some experiments are warranted to be tested,
including pharmacokinetics and pharmacodynamics of BZDs,
determination of the presence of peripheral receptors in the
salivary glands (Sawaki et al., 1995), physiological adaptation
Graphic 2 | Box-plots to Cell Volume (CV -µm3) according to the
groups treated for: 30 and 60 days with saline (C30 and C60
respectively); pilocarpine (P60), lorazepam (L30), lorazepam and saline
(LS60), and lorazepam and pilocarpine (LP60). Comparisons with p <
0.05: L30 × C30; P60 × LS60; C60 × LS60. CI 95% = 95% confidence
interval. Data obtained from findings reported by Rinaldi et al. (2015).
Graphic 3 | Box-plots to calponin index (C) according to the groups
treated for: 30 and 60 days with saline (C30 and C60 respectively);
pilocarpine (P60), lorazepam (L30), lorazepam and saline (LS60), and
lorazepam and pilocarpine (LP60). Comparisons with p < 0.05: L30 ×
C30; LP60 × C60. CI 95% = 95% confidence interval.
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FIGURE 1 | Rat parotid gland submitted to 30 days with lorazepam
(L30) showing myoepithelial cells in brown (immunohistochemical
staining of calponin, original magnification 400 x). L30 showed higher
number of myoepithelial cells when compared to C30.
FIGURE 2 | Rat parotid gland submitted to 30 days with saline (C30)
showing myoepithelial cells in brown (immunohistochemical staining
of calponin, original magnification 400 x).
when using psychotropic drugs, change in the sensitivity of the
receptors during chronic use of psychotropics, and the activity of
the myoepithelial, acinar, and ductal cells.
BZDs act selectively in GABAA receptors, which intensify
GABA response, making it easier to open the chloride
channel (Zaclikevis et al., 2009). The activation of GABAA
receptors increases conductance to the chloride ion, which
is found in greater concentrations on the external surface
of the membrane. As the chloride flow in the concentration
gradient, hyperpolarization of the post-synaptic membrane
occurs, (Zaclikevis et al., 2009). In this manner, an intensification
of the inhibitory activity of the CNS occurs when BZD is
administered.
GABAA receptors can be both central and peripheral (located
in the salivary glands) (Okubo and Kawaguchi, 2013). Kosuge
et al. (2009) demonstrated the presence of peripheral GABAA
receptors in the acinar cells of parotid and submandibular glands
of rats. The expression of receptors in the salivary glands is less
than what was found in the CNS (Howard et al., 2014).
Graphic 4 | Box-plots to Proliferating Cell Nuclear Antigen index
(PCNA) according to the groups treated for: 30 and 60 days with saline
(C30 and C60 respectively); pilocarpine (P60), lorazepam (L30),
lorazepam and saline (LS60), and lorazepam and pilocarpine (LP60).
None differences were observed. CI 95% = 95% confidence interval.
Numerous studies, both on human and animals, have
demonstrated that BZDs cause a reduction in salivary flow, with
severe oral side effects (De Almeida Pdel et al., 2008; Femiano
et al., 2008). BZDs act to induce reduction in salivary flow
through GABAA receptors located in the salivary glands as well
as through indirect actions of the CNS on the salivary glands
mediating central GABAA receptors (Kujirai et al., 2002; Okubo
and Kawaguchi, 2013). In addition to inhibiting the muscarinic
receptors present in the salivary glands, which are responsible for
the salivary flow, BZDs also can affect the transport of chloride
and the calcium influx, which can lead to fluid secretion. As
a result, a reduction in the salivary secretion activity occurs.
BZDs can also inhibit β-adrenergic receptors, in turn blocking
the release of amylase from rat parotid glands (Okubo and
Kawaguchi, 2013).
The present study demonstrated that when the treatment with
BZDs extended for 60 days, the reduction in SSFRwas found to be
not significantly different when compared to the control group. It
is known that prolonged use of psychotropic drugs is responsible
for changes in the sensitivity of the receptors (Howard et al.,
2014). The therapeutic and collateral effects of a drug gradually
diminishes when administered in a continuous or repeated
manner, which can in turn cause desensitivity, resistance, or
tolerance to the drug. A physiological adaptation can also occur.
Hence, it is common to observe that both therapeutic and
collateral effects of drugs tend to diminish with the duration of
administration, despite the continuous use of the drug (Howard
et al., 2014). Thus, it can be concluded that the weakest reduction
of SSFR in rats treated for 60 days occurred due to the effects of
tolerance and adaptability of the psychotropic drugs.
The absence of a statistically significant difference in the SSFR
among the C60, MS60, and LS60 groups suggests that there
was in fact a reestablishment of normal SSFR 30 days after
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TABLE 3 | Average values and standard deviation of studied variables according to the groups treated with pilocarpine (P60), saline (C60), midazolam and
saline (MS60), and midazolam and pilocarpine (MP60).
Group P60 C60 MS60 MP60
X DP X DP X DP X DP
SSFR (mL/min)δ 0.066 ± 0.027a 0.052 ± 0.028 0.022 ± 0.005a 0.038 ± 0.028
CV (µm3)δ 5.825.42 ± 1.968.07ab 6.505.56 ± 3.343.48c 8.143.93 ± 3.470.78a 9.152.06 ± 4.605.78bc
C 21.1 ± 7.385a 13.6 ± 4.788a 15.6 ± 6.221b 14.3 ± 6.147b
PCNA 46.8 ± 13.505 50 ± 17.530 39 ± 14.110a 67. ± 19.102a
δValues obtained from findings reported by Rinaldi et al. (2015); SSFR (mL/min), salivary flow stimulated in millimeters per minute; CV, Cell volume in square micrometers; PCNA,
Proliferating Cell Nuclear Antigen; C, Antibody against calponin antigen; X, average; SD, standard deviation; p, p-value of ANOVA; Similar letter represents statistically significant
difference between the groups.
FIGURE 3 | Rat parotid gland submitted to pilocarpine with midazolam
(MP60) showing acinar and ductal cells in proliferation in brown nuclei
(immunohistochemical staining of PCNA, original magnification 400 x).
MP60 showed higher PCNA as compared to MS60.
administration of the drugs (Table 3). However, these data must
be analyzed carefully, given that the reduction of SSFR of more
than 50% lead to it relevant detrimental clinical consequences
(C60—0.052 mL/min; MS60—0.022 mL/min).
One of the main effects of anxiolytics and hypnotics is the
myorelaxant action. The myoepithelial cells, though classified
as non-muscular cells, present an accentuated capacity of
contraction. The cytoplasm contains numerous contractible
actin and myosin microfilaments, intermediary filaments from
the cytokeratin 14 family, and typical structures of smooth
muscle fibers (Rao et al., 2014). The myoepithelial cells perform
contraction functions, contributing to the drainage of the
secretion from the secretory and ductal units (Rao et al., 2014).
Thus, it is suggested that the myorelaxant activity caused by the
anxiolytics can be, in part, responsible for the reduction of the
SSFR of rats treated with lorazepam and midazolam.
The chronic use of lorazepam for 30 days (L30) and 60 days
(LS60 and LP60) induced a significant increase in the number
of myoepithelial cells when compared to the saline groups
(C30 and C60). For the groups that received midazolam (M30,
MS60, and MP60), this difference did not occur (Tables 2, 3).
Here, the important qualitative and quantitative differences
FIGURE 4 | Rat parotid gland submitted to midazolam and saline
(MS60) showing acinar and ductal cells in proliferation in brown nuclei
(immunohistochemical staining of PCNA, original magnification 400 x).
in the pharmacokinetics when comparing midazolam and
lorazepam need to be discussed. Lorazepam (examples of
commercial names: Lorax R©, Mesmerin R©) is a drug that does
not produce active metabolites. It is metabolized through its
direct connection with a glycoside radical, a process that is
faster than oxidation. In addition, lorazepam has a short half-
life (12–18 h).By contrast, midazolam (examples of commercial
names: Dormonid R©, Dormire R©) contains an active metabolite
(hydroxylated derivative) with a half-life of 2 h (De Almeida
et al., 2012). The half-life of midazolam is also short (<6 h).
Considering that lorazepam has a half-life of up to three times
as long as midazolam, its effects last longer, which can explain the
significant changes in the salivary glands. BZDs, as liposoluble
drugs, are released through the salivary flow and can circulate for
a prolonged time in the saliva (De Almeida et al., 2012).
The myoepithelial cells have a contractile function, are
involved in aiding the salivary secretion, and are located around
the acinar cells and in the interspersed portion of the ductal cells
(Rao et al., 2014). It is valid to speculate that in an activity to
compensate for the lack of saliva, the organism, in an attempt
to increase the activity of the myoepithelial cells to expel the
retained saliva, induces an increase in the number of these
cells so that they, in their function of contractility, aid in the
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release of the retained saliva. Burgess et al. (1996) showed,
through immunohistochemical studies performed on atrophic
parotid glands of rats caused by ductal cell obstruction, that the
myoepithelial cells are capable of proliferating, especially when
caused by an injury to the gland itself. This finding suggests that
lorazepam may well be able to act as a chemical agent capable of
unleashing mitoses and, consequently, increasing the number of
myoepithelial cells.
In the present study, the administration of pilocarpine
associated with lorazepam over a 60-day period was able to
reestablish the normal SSFR (C60, LS60, and LP60 groups),
in turn proving its cholinergic agonist capacity. As it presents
a cholinomimetic action, the pilocarpine activates the M3
muscarinic receptors present in the salivary glands, promoting
an increase in the release of salivary secretion. It is still rather
unclear exactly how these mechanisms work. Kujirai et al. (2002)
reported that diazepam was capable of producing a reduction
in the SSFR, and in the acinar cells of the rat parotid glands,
diazepam induced an acceleration of the chloride influx as well
as an inhibition of the eﬄux.
When pilocarpine was associated with midazolam, an increase
in the proliferation of acinar and ductal cells and a reduction of
the number of myoepithelial cells were observed when compared
to the group that received midazolam and saline solution. This
may be the consequence of a pharmacological synergism or of
pharmacodynamics between midazolam and pilocarpine. It is
well-known that the association of the two drugs can result in
a pharmacological synergism, in which the combined effect of
the two substances proves to be greater than the sum of each
one separately (Zaclikevis et al., 2009; De Almeida et al., 2012).
On the other hand, pharmacodynamics results from the action of
the drugs involved in the same receptor. One drug can increase
the effect of the agonist by stimulating the receptivity of its
cellular receptor or by inhibiting the enzymes that inactivate it
in the location where the action takes places. The reduction in
effect may be due to the competition for the same receptor, with
the agonist having a greater affinity (Zaclikevis et al., 2009; De
Almeida et al., 2012).
Ouchi et al. (2011) evaluated the modulation of GABAA
receptor, adrenoceptor, and muscarinic receptor by diazepam
in rat parotid glands. This study suggested that uninterrupted
administration of diazepam changes the connection for
β-adrenoceptor and GABAA receptor binding sites in parotid
gland membranes, and changes in these binding sites may
be correlated to the diazepam-induced inhibition of salivary
secretion. This study demonstrated that the group of animals that
received BZDs for 1 month showed a reduction in the number
of proliferating acinar cells, as verified by PCNA staining. These
results have contributed to the hypothesis that BZDs do in fact
promote suppression in the parotid gland.
Rinaldi et al. (2015) confirmed that chronic administration of
midazolam and lorazepam reduced the number of acinar cells
in the parotid glands of rats, which may have contributed to
the reduction of salivary flow. The association of midazolam
with pilocarpine led to the reestablishment of acinar cells, which
may have favored the restoration of the salivary flow, as shown
above. Once again, the suppression action of BZDs on the salivary
glands was observed, in turn reducing the salivary flow; however,
pilocarpine has contributed to a reversal effect.
Okubo and Kawaguchi (2013) carried out an important
investigation on anxiolytics, BZDs, and salivary glands. This
study used a rat submandibular gland perfusion method to
investigate the suppressor regulation of the GABAA receptor
and showed that salivary secretion is inhibited by bicuculline,
a GABA(A)-receptor [GABA(A)-R] antagonist, in rat salivary
glands. This finding represents one step toward a better
understanding of the role of GABAA receptor in the salivary
gland, reinforcing the results from the present study, which
confirmed that when anxiolytics (lorazepam and/or midazolam)
were administered together with pilocarpine (a cholinergic
agonist), a reversal of the suppression of the release of the salivary
secretion could be observed, including a restorative action of the
salivary flow.
A potential limitation of our analysis reside in the fact
that, although the utmost care was taken to ensure a proper
calibration, the analysis of the histological data were perfomed
by a single observer.
Our eye-opening study investigated how pilocarpine, a
cholinergic agonist, may act in the GABAA receptor on the
salivary gland.
CONCLUSION
The histomorphometric revealed that, after the long-term
treatment anxiolytics drugs: increase the cellular volume
(hypertrophy acinar), we suggested that it could be due to
blockage of the stimulus on the cholinergic receptors of the
parotid glands contributed to the reduction in salivary flow.
The effects of Midazolam per 30 days: reducing the salivary
flow rate, increase Cell volume, results of immunohistochemistry
the work revealed that: Calponin showed no interference on
myopithelial cell neither PCNA.
The main results is that myoepithelial cells proved to be more
sensitive to the effects of BZDs than acinar and ductal cells in rat
parotid glands.
The effects of Midazolam per 60 days: Midazolam plus
Pilocarpine showed a tendency to increase the salivary flow
rate when compared with only Midazolam, Midazolam plus
Pilocarpine not increase the number of myopithelial cell, neither
Midazolam plus saline, but Midazolam plus Pilocarpine increase
of proliferating acinar and ductal cell when compared with only
Midazolam.
The effect of Lorazepam per 30 days: reducing the salivary
flow rate, increase Cell volume, results of immunohistochemistry
the work revealed that: Calponin showed increase the number of
myopithelial cell, but none interference of PCNA.
The effect of Lorazepam per 60 days: Lorazepam plus
Pilocarpine increase the salivary flow rate when compared
with only Pilocarpine, Lorazepam plus Pilocarpine increase the
number of myopithelial cell, but none interference of PCNA.
On the other hand, the treatment with Pilocarpine led to
the reestablishment of the number of myoepitelial cells on
the Midazolam plus Pilocarpine, which may have favored the
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restoration of salivary flow rate. This is the main action of
Pilocarpine.
The chronic administration per 30 days of Lorazepam and
Midazolam proved to be able of decrease salivary flow rate, but
there are some difference between these groups, once Lorazepam
has long bioavailability when compare Midazolam (short
bioavailability) and pharmacokinetic and pharmacodynamic
differences justifying the different results shown by these
BZDs.
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